Minnesota health officials have kept sloppy records of medical cannabis operations and need to step up oversight of the growing program, the state’s legislative watchdog said in a report released Tuesday.
Internal controls from the Department of Health were „generally not adequate” in a slew of areas, from enrolling patients and processing fees to testing and tracking the drugs, the Office of the Legislative Auditor found. The audit was conducted from July 2016 through December 2018.
„Internal controls are particularly important for the state’s medical cannabis program due to the federal classification of marijuana as a Schedule I controlled substance and the risk of its diversion for unauthorized purposes,” the report said.